Pathophysiology of autism spectrum disorders: Revisiting gastrointestinal involvement and immune imbalance
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (29) , 9942-51
Abstract
Autism spectrum disorders (ASD) comprise a group of neurodevelopmental abnormalities that begin in early childhood and are characterized by impairment of social communication and behavioral problems including restricted interests and repetitive behaviors. Several genes have been implicated in the pathogenesis of ASD, most of them are involved in neuronal synaptogenesis. A number of environmental factors and associated conditions such as gastrointestinal (GI) abnormalities and immune imbalance have been linked to the pathophysiology of ASD. According to the March 2012 report released by United States Centers for Disease Control and Prevention, the prevalence of ASD has sharply increased during the recent years and one out of 88 children suffers now from ASD symptoms. Although there is a strong genetic base for the disease, several associated factors could have a direct link to the pathogenesis of ASD or act as modifiers of the genes thus aggravating the initial problem. Many children suffering from ASD have GI problems such as abdominal pain, chronic diarrhea, constipation, vomiting, gastroesophageal reflux, and intestinal infections. A number of studies focusing on the intestinal mucosa, its permeability, abnormal gut development, leaky gut, and other GI problem raised many questions but studies were somehow inconclusive and an expert panel of American Academy of Pediatrics has strongly recommended further investigation in these areas. GI tract has a direct connection with the immune system and an imbalanced immune response is usually seen in ASD children. Maternal infection or autoimmune diseases have been suspected. Activation of the immune system during early development may have deleterious effect on various organs including the nervous system. In this review we revisited briefly the GI and immune system abnormalities and neuropeptide imbalance and their role in the pathophysiology of ASD and discussed some future research directions.Keywords
This publication has 120 references indexed in Scilit:
- Increased Anti-Phospholipid Antibodies in Autism Spectrum DisordersMediators of Inflammation, 2013
- Maternal immune activation and strain specific interactions in the development of autism-like behaviors in miceTranslational Psychiatry, 2013
- Application of Novel PCR-Based Methods for Detection, Quantitation, and Phylogenetic Characterization of Sutterella Species in Intestinal Biopsy Samples from Children with Autism and Gastrointestinal DisturbancesmBio, 2012
- CNVs: Harbingers of a Rare Variant Revolution in Psychiatric GeneticsCell, 2012
- Mechanisms of chylomicron uptake into lactealsAnnals of the New York Academy of Sciences, 2010
- Role of the brain‐derived neurotrophic factor at glutamatergic synapsesBritish Journal of Pharmacology, 2008
- Expression of cholera toxin B–proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non‐obese diabetic micePlant Biotechnology Journal, 2007
- Strong Association of De Novo Copy Number Mutations with AutismScience, 2007
- Calcitonin gene‐related peptide enhances release of native brain‐derived neurotrophic factor from trigeminal ganglion neuronsJournal of Neurochemistry, 2006
- Receptor‐mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory systemThe FASEB Journal, 2006